Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-29

Clinical Trial Update: The Effect of Probiotic and Zinc Supplementation in Patients With Gastroesophageal Reflux Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on probiotic and zinc supplementation for gastroesophageal reflux disease. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic (probiotic)
  • ZINC (Zinc chloride)

Snippet

Sponsor: Ain Shams University | Conditions: Gastro-oesophageal Reflux Disease | Phase 4 | Status: NOT_YET_RECRUITING